Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia.

Bibliographic Details
Title: Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia.
Authors: Lyu, Aram, Humphrey, Ryan S., Nam, Seo Hee, Durham, Tyler A., Hu, Zicheng, Arasappan, Dhivya, Horton, Terzah M., Ehrlich, Lauren I. R.
Source: Nature Communications; 10/7/2023, Vol. 14 Issue 1, p1-17, 17p
Subject Terms: LYMPHOBLASTIC leukemia, CELL adhesion, INSULIN receptors, ACUTE leukemia, FOCAL adhesion kinase, INTEGRINS, MYELOID cells, T cells, MYELOID differentiation factor 88
Abstract: We previously found that T-cell acute lymphoblastic leukemia (T-ALL) requires support from tumor-associated myeloid cells, which activate Insulin Like Growth Factor 1 Receptor (IGF1R) signaling in leukemic blasts. However, IGF1 is not sufficient to sustain T-ALL in vitro, implicating additional myeloid-mediated signals in leukemia progression. Here, we find that T-ALL cells require close contact with myeloid cells to survive. Transcriptional profiling and in vitro assays demonstrate that integrin-mediated cell adhesion activates downstream focal adhesion kinase (FAK)/ proline-rich tyrosine kinase 2 (PYK2), which are required for myeloid-mediated T-ALL support, partly through activation of IGF1R. Blocking integrin ligands or inhibiting FAK/PYK2 signaling diminishes leukemia burden in multiple organs and confers a survival advantage in a mouse model of T-ALL. Inhibiting integrin-mediated adhesion or FAK/PYK2 also reduces survival of primary patient T-ALL cells co-cultured with myeloid cells. Furthermore, elevated integrin pathway gene signatures correlate with higher FAK signaling and myeloid gene signatures and are associated with an inferior prognosis in pediatric T-ALL patients. Together, these findings demonstrate that integrin activation and downstream FAK/PYK2 signaling are important mechanisms underlying myeloid-mediated support of T-ALL progression. Tumor-associated myeloid cells directly support progression of T-cell acute lymphoblastic leukemia (TALL). Here, the authors show that T-ALL cells must contact myeloid cells and activate integrin signaling and downstream FAK/PYK2 kinases to survive. [ABSTRACT FROM AUTHOR]
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:20411723
DOI:10.1038/s41467-023-41925-z
Published in:Nature Communications
Language:English